Rubicon Research Secures ₹619 Crore from Anchor Investors Before IPO Launch
Rubicon Research, a Mumbai-based pharmaceutical company, has secured ₹619 crore from anchor investors ahead of its public issue. The strong anchor round signals institutional trust in the company’s model, its export focus, and its R&D pipeline.
Continue Reading on Meyka
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →